High-throughput microtiter well-based chemiluminometric genotyping of 15 HBB gene mutations in a dry-reagent format.

BACKGROUND Hemoglobinopathies are the most common inherited diseases worldwide. Various methods for genotyping of hemoglobin, beta (HBB) gene mutations have been reported, but there is need for a high sample-throughput, cost-effective method for simultaneous screening of several mutations. We report a method that combines the high detectability and dynamic range of chemiluminescence with the high allele-discrimination ability of probe extension reactions for simultaneous genotyping of 15 HBB mutations in a high sample-throughput, dry-reagent format. METHODS We genotyped the HBB mutations IVSI-110G>A, CD39C>T, IVSI-1G>A, IVSI-6T>C, IVSII-745C>G, IVSII-1G>A, FSC6GAG>G-G, -101C>T, FSC5CCT>C-, IVSI-5G>A, FSC8AAG>-G, -87C>G, IVSII-848C>A, term+6C>G, and HbS (cd6GAG>GTG). The method used comprises the following: (a) duplex PCR that produces fragments encompassing all 15 mutations, (b) probe extension reactions in the presence of fluorescein-modified dCTP, using unpurified amplicons, and (c) microtiter well-based assay of extension products with a peroxidase-antifluorescein conjugate and a chemiluminogenic substrate. We used lyophilized dry reagents to simplify the procedure and assigned the genotype by the signal ratio of the normal-to-mutant-specific probe. RESULTS We standardized the method by analyzing 60 samples with known genotypes and then validated by blindly genotyping 115 samples with 45 genotypes. The results were fully concordant with sequencing. The reproducibility (including PCR, probe extension reaction, and chemiluminometric assay) was studied for 20 days, and the CVs were 11%-19%. CONCLUSIONS This method is accurate, reproducible, and cost-effective in terms of equipment and reagents. The application of the method is simple, rapid, and robust. The microtiter well format allows genotyping of a large number of samples in parallel for several mutations.

[1]  D. Weatherall.  The global problem of genetic disease , 2005, Annals of human biology.

[2]  J. Lacroix,et al.  Analytical validation of the tag-it high-throughput microsphere-based universal array genotyping platform: application to the multiplex detection of a panel of thrombophilia-associated single-nucleotide polymorphisms. , 2004, Clinical chemistry.

[3]  Shinichi Ishida,et al.  Convenient single-nucleotide polymorphism typing from whole blood by probe extension and bioluminescence detection. , 2004, Clinical chemistry.

[4]  Elaine Lyon,et al.  Genotyping of single-nucleotide polymorphisms by high-resolution melting of small amplicons. , 2004, Clinical chemistry.

[5]  E. Naylor,et al.  A high throughput beta-globin genotyping method by multiplexed melting temperature analysis. , 2004, Molecular genetics and metabolism.

[6]  Göran Stemme,et al.  Single nucleotide polymorphism analysis by allele-specific primer extension with real-time bioluminescence detection in a microfluidic device. , 2003, Journal of chromatography. A.

[7]  Rapid, simultaneous genotyping of five common Southeast Asian beta-thalassemia mutations by multiplex minisequencing and denaturing HPLC. , 2003, Clinical chemistry.

[8]  Theodore K Christopoulos,et al.  Combined flash- and glow-type chemiluminescent reactions for high-throughput genotyping of biallelic polymorphisms. , 2003, Analytical biochemistry.

[9]  Carl T Wittwer,et al.  High-resolution genotyping by amplicon melting analysis using LCGreen. , 2003, Clinical chemistry.

[10]  Christina Vrettou,et al.  Rapid screening of multiple beta-globin gene mutations by real-time PCR on the LightCycler: application to carrier screening and prenatal diagnosis of thalassemia syndromes. , 2003, Clinical chemistry.

[11]  J. Old,et al.  Screening and genetic diagnosis of haemoglobin disorders. , 2003, Blood reviews.

[12]  S. Chong,et al.  Multiplex minisequencing screen for common Southeast Asian and Indian beta-thalassemia mutations. , 2003, Clinical chemistry.

[13]  Marco Seri,et al.  Analysis of clinically relevant single-nucleotide polymorphisms by use of microelectronic array technology. , 2002, Clinical chemistry.

[14]  B. Dallapiccola,et al.  Reliability of DHPLC in mutational screening of β‐globin (HBB) alleles , 2002, Human mutation.

[15]  B. Dallapiccola,et al.  Reliability of DHPLC in mutational screening of beta-globin (HBB) alleles. , 2002, Human Mutation.

[16]  K. Okano,et al.  Quantitative detection of single nucleotide polymorphisms for a pooled sample by a bioluminometric assay coupled with modified primer extension reactions (BAMPER). , 2001, Nucleic acids research.

[17]  M Ronaghi,et al.  Method enabling pyrosequencing on double-stranded DNA. , 2000, Analytical biochemistry.

[18]  S. P. Fodor,et al.  Determination of ancestral alleles for human single-nucleotide polymorphisms using high-density oligonucleotide arrays , 1999, Nature Genetics.

[19]  R. Galanello,et al.  Evaluation of the BeTha Gene 1 Kit for the Qualitative Detection of the Eight Most Common Mediterranean β‐Thalassemia Mutations , 1998, American journal of hematology.

[20]  L Peltonen,et al.  Minisequencing: a specific tool for DNA analysis and diagnostics on oligonucleotide arrays. , 1997, Genome research.

[21]  M. Tzetis,et al.  Prenatal diagnosis of the thalassaemia syndromes by rapid DNA analytical methods. , 1997, Molecular human reproduction.

[22]  S. S. Deshpande.  Reagent Formulations and Shelf Life Evaluation , 1996 .

[23]  S. S. Deshpande.  Enzyme Immunoassays: From Concept to Product Development , 1996 .

[24]  R. Gibbs,et al.  Detection and genetic analysis of β‐thalassemia mutations by competitive oligopriming , 1995 .

[25]  Jeffrey D. Wall,et al.  Rapid and simultaneous typing of hemoglobin S, hemoglobin C, and seven Mediterranean beta-thalassemia mutations by covalent reverse dot-blot analysis: application to prenatal diagnosis in Sicily. , 1993, Blood.

[26]  E. Rappaport,et al.  Detection of the most common mutations causing beta-thalassemia in Mediterraneans using a multiplex amplification refractory mutation system (MARMS). , 1992, PCR methods and applications.

[27]  R. Lindeman,et al.  Polymerase chain reaction (PCR) mutagenesis enabling rapid non‐radioactive detection of common β‐thalassaemia mutations in Mediterraneans , 1991, British journal of haematology.

[28]  D. Weatherall,et al.  Rapid detection and prenatal diagnosis of β-thalassaemia: studies in Indian and Cypriot populations in the UK , 1990, The Lancet.

[29]  R. Fodde,et al.  Denaturing gradient gel electrophoresis and direct sequencing of PCR amplified genomic DNA: a rapid and reliable diagnostic approach to beta thalassaemia , 1990, British journal of haematology.

[30]  C. Levenson,et al.  Diagnosis of sickle cell anemia and beta-thalassemia with enzymatically amplified DNA and nonradioactive allele-specific oligonucleotide probes. , 1988, The New England journal of medicine.

[31]  D. Seligson,et al.  Clinical Chemistry , 1965, Bulletin de la Societe de chimie biologique.